Source: Revenio Group Oyj
Revenio Group Corporation Stock Exchange Release 20 May 2014 at 13.30 Hrs.
CHANGES IN REVENIO GROUP CORPORATION'S MANAGEMENT
As part of the change in Group structure, and owing to Revenio's focus on health
technology, CFO Pekka Raatikainen and Development Director Juha Kujala will be
leaving the company on 22 May 2014. Juha Kujala, LL.M., will go and work for
Magnusson Helsinki Attorneys-at-Law Ltd but will continue as secretary to
Revenio Group Corporation's Board of Directors.
Revenio Group's Financial Manager Jasmin Kuittinen has been appointed acting
As of 22 May 2014, Revenio Group Corporation's Management Team will consist of
President & CEO Olli-Pekka Salovaara (Chair), Icare Finland Oy's CEO Timo
Hildén, Technology and Services' Segment Director Riku Lamppu and acting CFO
Jasmin Kuittinen. The Management Team is presented at www.reveniogroup.fi/en.
For additional information:
President & CEO Olli-Pekka Salovaara,
tel. +358 40 567 5520
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
The Revenio Group in brief
Revenio is a Finnish health tech group whose core business is tonometers. The
Revenio Health Tech segment comprises primarily of the business operations of
Icare Finland Oy. The widely patented Icare product family is the current
cornerstone of the Group's success. Revenio seeks vigorous growth in health
technology, both organically and through acquisitions and mergers.
The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products and
services in their industry. These businesses are extremely profitable in their
industries and generate positive cash flow.
In 2013, the Revenio Group's net sales totaled EUR 25.7 million, with its
operating margin standing at 21.7 %. The Revenio Group Corporation is listed on
NASDAQ OMX Helsinki.